{"id":"NCT00077623","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.","officialTitle":"A Randomized, Controlled, Open-Label, Multi- Center, Parallel-Group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Subcutaneously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-03","primaryCompletion":"2005-09","completion":"2005-09","firstPosted":"2004-02-13","resultsPosted":"2016-04-26","lastUpdate":"2016-05-25"},"enrollment":572,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia"],"interventions":[{"type":"DRUG","name":"epoetin alfa or beta","otherNames":[]},{"type":"DRUG","name":"methoxy polyethylene glycol-epoetin beta (Mircera)","otherNames":[]},{"type":"DRUG","name":"methoxy polyethylene glycol-epoetin beta (Mircera)","otherNames":[]}],"arms":[{"label":"RO0503821 (1x/2 Weeks)","type":"EXPERIMENTAL"},{"label":"RO0503821 (1x/4 Weeks)","type":"EXPERIMENTAL"},{"label":"Epoetin Reference","type":"ACTIVE_COMPARATOR"}],"summary":"This study will assess the efficacy and safety of subcutaneous (sc) Mircera given as maintenance treatment for renal anemia in chronic kidney disease patients on dialysis who were previously receiving sc epoetin. The anticipated time on study treatment is 1-2 years and the target sample size is 100-500 individuals.","primaryOutcome":{"measure":"Mean Change in Hemoglobin Concentration From Baseline to Evaluation Periods","timeFrame":"Baseline (Week -4 to Week -1) and Evaluation period (Week 29 to Week 36)","effectByArm":[{"arm":"RO0503821 (1x/2 Weeks)","deltaMin":0,"sd":0.96},{"arm":"RO0503821 (1x/4 Weeks)","deltaMin":-0.11,"sd":0.97},{"arm":"Epoetin Reference","deltaMin":-0.12,"sd":1.04}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":2},"locations":{"siteCount":90,"countries":["United States","Belgium","Brazil","Czechia","Denmark","Finland","France","Germany","Hungary","Italy","Mexico","New Zealand","Panama","Poland","Puerto Rico","South Africa","Spain","Sweden","Taiwan","Thailand","United Kingdom"]},"refs":{"pmids":["36791280"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":70,"n":190},"commonTop":["Hypertension","Procedural hypotension","Nasopharyngitis","Headache","Muscle spasms"]}}